Ann Dermatol.  2013 Feb;25(1):114-116. 10.5021/ad.2013.25.1.114.

Refractory Atopic Dermatitis in Childhood: Improvement with Methotrexate?

• Park YW
• Yeom KB
• Kim KH

• KMID: 2265986
• DOI: http://doi.org/10.5021/ad.2013.25.1.114

Abstract

No abstract available.

MeSH Terms

Dermatitis, Atopic

Figure

• 

  Fig. 1 Generalized multiple, intensely pruritic, excoriated erythematous scaling papules, and plaques, refractory to treatment with first-line treatment modalities and ciclosporin.

• 

  Fig. 2 Seven weeks after initiation of treatment with methotrexate, substantial improvement of the patient's atopic eczema was noted.

Reference

1. Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ. 2006. 332:584–588.

2. Weatherhead SC, Wahie S, Reynolds NJ, Meggitt SJ. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol. 2007. 156:346–351.

3. Heydendael VM, Spuls PI, Opmeer BC, de Borgie CA, Reitsma JB, Goldschmidt WF, et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med. 2003. 349:658–665.

4. Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, et al. ICCAD II Faculty. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003. 148:Suppl 63. 3–10.

5. de Jager ME, de Jong EM, van de Kerkhof PC, Seyger MM. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol. 2010. 62:1013–1030.